Le Lézard
Classified in: Transportation, Covid-19 virus
Subjects: HSP, CSR

Toyota: We Are Here For You!


PLANO, Texas, March 27, 2020 /PRNewswire/ -- As a result of the COVID-19 pandemic, Toyota Motor North America, Inc. (TMNA) continues to assist those in need with essential supplies, emergency relief and is providing on-going support to many local organizations and non-profits. These efforts include monetary, "in-kind" donations, plus utilizing several of the company's North American facilities to fabricate face shields while collaborating with medical device companies to speed the manufacture of ventilators, respirators and other vital devices for hospitals.

"Toyota's core value has always been to contribute to society in meaningful ways beyond providing mobility for our customers," said Ted Ogawa, incoming CEO, TMNA. "With our plants idled and our dealers focused on servicing customers, we are eager to contribute our expertise and know-how in order to help quickly bring to market the medical supplies and equipment needed to combat the COVID crisis. Our message to the medical equipment community is we are here to help, please utilize our expertise."

For medical device companies and related businesses seeking support in the areas of manufacturing, engineering, supply chain and purchasing, all inquiries can be sent to: [email protected]  

The company has also taken several actions in support of curbing the spread of the virus and helping communities across North America, including:

For a complete list of donations from our Toyota companies, employees and dealers that are helping to assist local communities, please visit Toyota's COVID-19 page at:  https://pressroom.toyota.com/topic/covid-19-information/.

About Toyota
Toyota (NYSE:TM) has been a part of the cultural fabric in the U.S. and North America for more than 60 years, and is committed to advancing sustainable, next-generation mobility through our Toyota and Lexus brands. During that time, Toyota has created a tremendous value chain as our teams have contributed to world-class design, engineering, and assembly of more than 40 million cars and trucks in North America, where we have 14 manufacturing plants, 15 including our joint venture in Alabama (10 in the U.S.), and directly employ more than 47,000 people (over 36,000 in the U.S.). Our 1,800 North American dealerships (nearly 1,500 in the U.S.) sold 2.7 million cars and trucks (2.4 million in the U.S.) in 2019.

Through the Start Your Impossible campaign, Toyota highlights the way it partners with community, civic, academic and governmental organizations to address our society's most pressing mobility challenges. We believe that when people are free to move, anything is possible. For more information about Toyota, visit www.toyotanewsroom.com.

CONTACT:
Victor Vanov
Toyota Motor North America, Inc.
469.292.1318

SOURCE Toyota Motor North America


These press releases may also interest you

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...



News published on and distributed by: